Studies suggest that hyperactivated STAT3 is key to pathology observed in COVID-19 patients, since STAT3 acts in a positive feedback loop with plasminogen activator inhibitor (PAI-1) leading to coagulopathy characterized by intravascular thrombi (44). This evidence concerns the gene SERPINB2 and COVID-19.